Skip to main content
. 2008 Feb;98(2):278–283. doi: 10.2105/AJPH.2005.080770

TABLE 2—

Changes in Performance of 24 Syringe Exchange Programs (SEPs), by Assembly AB136 (AB136) Status: California, 2000–2002

AB136 Approved (n = 14), No. (%) AB136 Unapproved (n = 10), No. (%)
Syringe dispensation categorya
    Improved 2 (14) 1 (10)
    Worsened 1 (7) 3 (30)
Active injection drug users
    Improved 3 (21) 3 (30)
    Worsened 1 (7) 1 (10
Syringe shortages
    Improved 3 (21) 1 (10)
    Worsened 0 (0) 4 (40)
Supply shortages
    Improved 1 (7) 2 (20)
    Worsened 1 (7) 2 (20)
Police harassment of SEP
    Improved 6 (43) 3 (30)
    Worsened 0 (0) 2 (20)
Police presence near SEP
    Improved 4 (28) 0 (0)
    Worsened 3 (21) 3 (30)
Police contact with SEP clients
    Improved 2 (14) 0 (0)
    Worsened 1 (7) 1 (10)
Political support
    Improved 4 (28) 3 (30)
    Worsened 3 (21) 1 (10)
On-site HIV testing
    Improved 1 (7) 0 (0)
    Worsened 2 (14) 0 (0)
On-site HCV testing
    Improved 3 (21) 2 (20)
    Worsened 2 (14) 1 (10)

Note. HCV = hepatitis C virus. Beginning in January 2000, Assembly AB136 protected operators of SEPs authorized by local jurisdictions (city or county) from criminal prosecution for distributing syringes and needles.

aPolicy that program uses for dispensing syringes to clients; 5 program types were observed: 1) unlimited, need-based syringe exchange, 2) unlimited 1-for-1 exchange plus 5 to 10 additional syringes, 3) limited 1-for-1 exchange plus 5 to 10 additional syringes that could be exchanged, 4) unlimited 1-for-1 exchange, and 5) strict 1-for-1 exchange with a limit on syringes exchanged per visit.